First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.49 USD 6.9% Market Closed
Updated: Mar 29, 2024

ADC Therapeutics SA
Other Liabilities

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Other Liabilities Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Other Liabilities
$8.9m
CAGR 3-Years
-55%
CAGR 5-Years
35%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Other Liabilities
CHf5.8m
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Other Liabilities
$238m
CAGR 3-Years
51%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Other Liabilities
CHf40.2m
CAGR 3-Years
-1%
CAGR 5-Years
-14%
CAGR 10-Years
-13%
Idorsia Ltd
SIX:IDIA
Other Liabilities
CHf258.5m
CAGR 3-Years
24%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Other Liabilities
CHf0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Other Liabilities?
Other Liabilities
8.9m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Liabilities amounts to 8.9m USD.

What is ADC Therapeutics SA's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
35%

Over the last year, the Other Liabilities growth was -65%. The average annual Other Liabilities growth rates for ADC Therapeutics SA have been -55% over the past three years , 35% over the past five years .